Yonhap Infomax NewsNov 25
Samsung invests in China’s Phrontline Biopharma via its Life Science Fund, targeting next-generation ADC cancer therapies and expanding global biotech partnerships.
#YonhapInfomax #Samsung #PhrontlineBiopharma #LifeScienceFund #ADCTechnology #BiotechInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=92277
Samsung Invests in China’s Phrontline Biopharma via Life Science Fund

Samsung invests in China’s Phrontline Biopharma via its Life Science Fund, targeting next-generation ADC cancer therapies and expanding global biotech partnerships.

Yonhap Infomax